United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

United-Guardian, Inc.

Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients. It operates through two segments, Taste, Nutrition & Health, and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and flavor solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for aqua feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, aroma molecules, cosmetic ingredients, and mint flavors, as well as specific application processes for such substances. This segment's products are used by manufacturers of perfumes, personal care and cosmetic products, cleaning products, detergents, air fresheners, and oral care products. It operates in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. Symrise AG was founded in 1874 and is headquartered in Holzminden, Germany.

Symrise AG

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.

United Guardian, Inc. manufactures cosmetic ingredients, pharmaceuticals, and specialty products. It also self-described as offering natural ingredients and formulations.

Metric
Company Name	United-Guardian, Inc.	Symrise AG
Symbol	UG	SY1
MSH ID	COM:U-G	COM:SYMRISE
Market	STOCKS	STOCKS
Sector	Consumer Defensive	Basic Materials
Industry	Household & Personal Products	Chemicals - Specialty
Country	US	DE
Stage
Employee Count	25	12.66K
Website	u-g.com	symrise.com
LinkedIn
Founders

Metric
Market Cap	43.88M	16.68B
Enterprise Value
Monthly Web Traffic		69.88K
Web Traffic Growth		0.68
Valuation
Raised Capital

Metric
Revenue	10.89M	5.01B
Revenue (LTM)
Revenue (NTM)
Gross Profit	5.41M	1.81B
EBITDA	2.97M	838.42M
Operating Income	2.86M	533.89M
Net Income	2.58M	358.64M
EPS	0.56	2.57
Diluted EPS	0.56	2.57
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score		96.36
28-Day Growth Score		64.55
90-Day Growth Score		79.77
365-Day Growth Score		42.25

Metric
Gross Profit Margin	0.51	0.37
Operating Profit Margin	0.30	0.12
EBITDA Margin	0.27	0.17
Net Profit Margin	0.26	0.08
Return on Equity	0.29	0.18
Return on Assets	0.23	0.08
Return on Capital Employed	0.30	0.14

COM:U-G

United Guardian, Inc.

Last Close

9.75

22/11 21:00

Market Cap

43.55M

Beta: -

Volume Today

7.61K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	15.40	48.29
P/B Ratio	3.65	3.81
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	5.88	3.48
EV Multiple	21.88	17.27

Metric
Days Sales Outstanding	60.04
Days Payables Outstanding	10.48	66.28
Days Inventory Outstanding	81.50	150.90
Operating Cycle	145.84	228.93
Cash Conversion Cycle	127.00	171.11
Asset Turnover	0.91	1.07

Metric
Operating Cash Flow	3.14M	694.94M
Free Cash Flow	3.14M	410.32M
Cash Flow to Debt	147.87	0.51
Operating Cash Flow/Sales	0.35	0.19
Free Cash Flow Yield	0.07	0.01

Metric
Cash & Equivalents	8.24M	414.00M
Accounts Receivable	-135.87K	-36.17M
Inventory	1.22M	1.32B
Goodwill		1.98B
Debt to Capitalization	0.00	0.40
Debt to Assets		0.33
Current Ratio	7.88	2.76
Quick Ratio	6.99	1.64

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.00
R&D to Revenue	0.04	0.06
SG&A to Revenue		0.06